General Information of Drug (ID: DMOZ669)

Drug Name
mRNA-1468
Indication
Disease Entry ICD 11 Status REF
Herpes zoster 1E91 Phase 2 [1]
Drug Type
Vaccine
Cross-matching ID
TTD ID
DWZX75

References

1 ClinicalTrials.gov (NCT05701800) A Phase 1/2, Randomized, Observer-Blind, Active-Controlled, Dose-Ranging Study to Evaluate the Safety, Reactogenicity and Immunogenicity of mRNA-1468, a Candidate Vaccine to Prevent Herpes Zoster (HZ) in Healthy Adults >=50 Years of Age. U.S.National Institutes of Health.